GARDP
Global Antibiotic Research and Development Partnership
- Website
- gardp.org · all feeds from this site
- Feed URL
http://gardp.org/feed/
Read it in your FeedListing reader
Or add to: Feedly Inoreader Raw feed
Latest posts
-
Strengthening WHO’s role in public health innovation: a PDP perspective
A joint policy paper from GARDP, DNDi, MMV and MDGH (October 2026) As the global health architecture undergoes reform, four product development partnerships (PDPs) outline the WHO functions that are critical to needs-driven health innovation and explain why these must be…
-
GARDP in India factsheet
GARDP in India overview
-
GARDP Statement: PAHO Plan of Action for Antimicrobial Resistance
The Global Antibiotic Research & Development Partnership (GARDP) welcomes the Pan American Health Organization’s (PAHO) Plan of Action for Antimicrobial Resistance (AMR). We recognize the Plan as a framework for Member States, non-State actors and health professionals to…
-
Q3 2026: 💊 Partnership in action: Advancing antibiotic R&D for AMR
Source
-
Webinar – From approval to access: A new model for delivering effective antibiotics
GARDP webinar, Tuesday, 27 October, 12pm CET Conversations on antibiotic access have tended to focus on two paradoxical truths: antibiotic overuse drives resistance as bacteria are overexposed to antibiotics, but so does antibiotic underuse as bacteria are either untreated or…
-
External Clinical Data Sharing for Secondary Research Use
This policy describes GARDP’s commitment to share for secondary research use anonymized participant level data obtained during GARDP-sponsored human subject research in a standardized way, while also protecting individuals’ privacy and complying with all relevant data protection…
-
Scientific Affairs and REVIVE fact sheet
Antibiotic access overview
-
Sepsis: A race against time – and against resistance.
11 September 2026 Published in the Tagesspiegel Background By Peter Beyer, Deputy Executive Director, the Global Antibiotic Research & Development Partnership (GARDP) Sepsis is often described as a race against time. Every hour that passes before treatment increases the risk of…
-
The Silent Killer Threatening Children
09 September 2026 Antimicrobial Resistance (AMR) and neonatal health crises have escalated into critical public health emergencies across Bangladesh, threatening national healthcare infrastructure and standard of living. Driven by the unregulated use of antibiotics, severe…
-
Blueprint to Combat Neonatal Sepsis and AMR in Bangladesh
08 September 2026 Sepsis, a severe bloodstream infection, has evolved into a major public health threat. When coupled with Antimicrobial Resistance (AMR), it directly imperils the future of newborns in Bangladesh. The first 28 days of life constitute an exceptionally fragile…